These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 19817511)
1. Preventing myocardial infarction and stroke with a simplified bundle of cardioprotective medications. Dudl RJ; Wang MC; Wong M; Bellows J Am J Manag Care; 2009 Oct; 15(10):e88-94. PubMed ID: 19817511 [TBL] [Abstract][Full Text] [Related]
2. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Anselmino M; Malmberg K; Ohrvik J; Rydén L; Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817 [TBL] [Abstract][Full Text] [Related]
4. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836 [TBL] [Abstract][Full Text] [Related]
5. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke. Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611 [TBL] [Abstract][Full Text] [Related]
6. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609 [TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure. Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290 [TBL] [Abstract][Full Text] [Related]
8. Comparison of two methodologies to analyze exposure to statins in an observational study on effectiveness. Maitland-van der Zee AH; Klungel OH; Stricker BH; Verschuren WM; Witteman JC; Stijnen T; Hofman A; Breteler MM; Leufkens HG; de Boer A J Clin Epidemiol; 2004 Mar; 57(3):237-42. PubMed ID: 15066683 [TBL] [Abstract][Full Text] [Related]
9. Use of combination evidence-based medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4). Spencer FA; Frederick PD; Goldberg RJ; Gore JM; Tiefenbrunn AJ; Am J Cardiol; 2005 Oct; 96(7):922-6. PubMed ID: 16188517 [TBL] [Abstract][Full Text] [Related]
10. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818 [TBL] [Abstract][Full Text] [Related]
12. Statin use and survival outcomes in elderly patients with heart failure. Ray JG; Gong Y; Sykora K; Tu JV Arch Intern Med; 2005 Jan; 165(1):62-7. PubMed ID: 15642876 [TBL] [Abstract][Full Text] [Related]
13. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810 [TBL] [Abstract][Full Text] [Related]
14. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387 [TBL] [Abstract][Full Text] [Related]
15. Diabetes and the HOPE study: implications for macrovascular and microvascular disease. Gerstein HC Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO survey. Sicard P; Zeller M; Dentan G; Laurent Y; Touzery C; L'huillier I; Janin-Manificat L; Lorgis L; Beer JC; Makki H; Rochette L; Cottin Y; Am J Hypertens; 2007 Nov; 20(11):1133-9. PubMed ID: 17954357 [TBL] [Abstract][Full Text] [Related]
17. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693 [TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836 [TBL] [Abstract][Full Text] [Related]
19. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362 [TBL] [Abstract][Full Text] [Related]
20. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Winkelmayer WC; Charytan DM; Levin R; Avorn J Am J Kidney Dis; 2006 Feb; 47(2):301-8. PubMed ID: 16431259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]